Skip to main content
Premium Trial:

Request an Annual Quote

Quantum-Si Laying off 12 Percent of Workforce

NEW YORK – Proteomics firm Quantum-Si announced in a document filed Monday with the US Securities and Exchange Commission that it plans to lay off roughly 12 percent of its workforce in Q1 as part of a restructuring effort.

The company, which had 153 employees as of Dec. 31 — the last time it reported its headcount — said the move is intended to decrease costs and streamline its organization.

The firm will incur up to $1 million in costs related to the restructuring, primarily due to cash severance payments and other severance benefits.

Quantum-Si's stock has struggled since the company went public in 2021 via a merger with a special purpose acquisition company that valued the firm at $1.46 billion. The company's shares peaked at $20.49 in February of that year, ended 2021 at $7.87, and continued to trend downward throughout 2022. In Tuesday morning trading on the Nasdaq, Quantum-Si shares were up 2 percent to $2.19.

At the end of 2022, the company launched its first commercial product, its Platinum protein sequencing platform. During Quantum-Si's recent presentation at the 41st Annual JP Morgan Healthcare Conference, CEO Jeff Hawkins said the firm will concentrate on building out commercial operations to support the Platinum launch this year.


The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.